GSA Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$278K Buy
2,618
+285
+12% +$30.3K 0.02% 1306
2025
Q1
$290K Sell
2,333
-1,779
-43% -$221K 0.03% 1180
2024
Q4
$506K Buy
+4,112
New +$506K 0.04% 878
2024
Q1
Sell
-1,689
Closed -$208K 1798
2023
Q4
$208K Buy
+1,689
New +$208K 0.02% 1306
2023
Q3
Sell
-2,039
Closed -$253K 1705
2023
Q2
$253K Buy
+2,039
New +$253K 0.03% 1144
2022
Q2
Sell
-4,333
Closed -$675K 1600
2022
Q1
$675K Buy
+4,333
New +$675K 0.09% 357
2020
Q2
Sell
-2,950
Closed -$294K 856
2020
Q1
$294K Buy
2,950
+412
+16% +$41.1K 0.07% 500
2019
Q4
$379K Buy
2,538
+64
+3% +$9.56K 0.04% 849
2019
Q3
$317K Sell
2,474
-2,826
-53% -$362K 0.04% 853
2019
Q2
$756K Buy
+5,300
New +$756K 0.08% 402
2019
Q1
Sell
-3,330
Closed -$413K 1550
2018
Q4
$413K Buy
+3,330
New +$413K 0.05% 656
2018
Q2
Sell
-2,067
Closed -$312K 1804
2018
Q1
$312K Buy
+2,067
New +$312K 0.02% 1296
2017
Q2
Sell
-2,695
Closed -$391K 1803
2017
Q1
$391K Buy
2,695
+379
+16% +$55K 0.02% 1238
2016
Q4
$253K Sell
2,316
-3,817
-62% -$417K 0.02% 1436
2016
Q3
$745K Sell
6,133
-4,509
-42% -$548K 0.04% 807
2016
Q2
$1.5M Buy
10,642
+2,341
+28% +$331K 0.08% 383
2016
Q1
$1.08M Sell
8,301
-5,214
-39% -$681K 0.07% 488
2015
Q4
$1.9M Sell
13,515
-45,460
-77% -$6.39M 0.09% 281
2015
Q3
$7.83M Buy
58,975
+50,564
+601% +$6.72M 0.39% 20
2015
Q2
$1.48M Sell
8,411
-6,055
-42% -$1.07M 0.06% 583
2015
Q1
$2.5M Sell
14,466
-7,468
-34% -$1.29M 0.1% 228
2014
Q4
$3.59M Buy
21,934
+14,277
+186% +$2.34M 0.25% 28
2014
Q3
$1.23M Sell
7,657
-5,167
-40% -$829K 0.06% 371
2014
Q2
$1.89M Buy
12,824
+1,631
+15% +$240K 0.08% 287
2014
Q1
$1.55M Sell
11,193
-9,884
-47% -$1.37M 0.11% 179
2013
Q4
$2.67M Buy
21,077
+5,469
+35% +$692K 0.21% 60
2013
Q3
$1.44M Sell
15,608
-9,173
-37% -$843K 0.11% 195
2013
Q2
$1.7M Buy
+24,781
New +$1.7M 0.2% 91